Sage Journals: Discover world-class research

Abstract

Background

Portal fibroblasts are newly identified, potentially fibrogenic liver cells that are distinct from hepatic stellate cells. The ectonucleotidase* nucleoside triphosphate diphosphohydrolase 2 (NTPDase2) is restricted to portal fibroblasts in the normal liver. However, the fate of NTPDase2 after bile duct ligation (BDL) is unknown.

Aims

The aim of this study was to assess the effect of experimental rat and disease-mediated human biliary cirrhosis on NTP-Dase2 expression in the liver.

Methods

Cirrhosis was induced in experimental rats via BDL and carbon tetrachloride (CCI₄) administration. Archived human liver biopsy specimens from normal liver, primary biliary cirrhosis, or hepatitis C cirrhosis were examined. Changes in expression of NTPDase2 were determined using confocal immunofluorescence, immunoblot, and real-time polymerase chain reaction.

Results

Confocal immunofluorescence demonstrated a decrease in NTPDase2 expression after BDL. Immunoblot and real-time polymerase chain reaction demonstrated a decrease in NTPDase2 expression by portal fibroblasts after BDL. No decrease in NTP-Dase2 protein was noted after CCI₄ administration, and NTPDase2 messenger ribonucleic acid was markedly up-regulated after CCI₄ administration. Confocal immunofluorescence demonstrated a shift of NTPDase2 expression from portal areas to central areas that colocalized with α-smooth muscle actin after CCI₄ administration. In human biopsy specimens, NTPDase2 expression was lost in cirrhosis owing to primary biliary cirrhosis, whereas NTPDase2 expression was shifted to bridging fibrous bands in cirrhosis owing to hepatitis C.

Conclusions

Loss of NTPDase2 is a common pathway in both rat and human manifestations of biliary cirrhosis. Conversely, in nonbiliary cirrhosis, NTPDase2 is shifted from the portal area to bridging fibrous bands. Elucidations of the mechanisms regulating NTP–Dase2 expression may lead to new therapeutic approaches to fibrotic liver disease.

Keywords

biliary cirrhosis cholestasis ecto-ATPase ectonucleotidase liver fibrosis

Get full access to this article

View all access options for this article.

References

Recipient data; pediatric transplantation: European Liver Transplant Registry 2003; [2 screens]. Available at http://www.eltr.org/publi/results.php3?id_rubrique=49 (accessed October 2003).

Kruglov

E.A.

, Jain

, Dranoff

J.A.

Isolation of primary rat liver fibroblasts.

J Invest Med 2002; 50: 179–84.

Dranoff

J.A.

, Kruglov

E.A.

, Robson

S.C.

The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver.

Hepatology 2002; 36: 1135–44.

Tuchweber

, Desmouliere

, Bochaton-Piallat

M.L.

Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.

Lab Invest 1996; 74: 265–78.

Kinnman

, Housset

Peribiliary myofibroblasts in biliary type liver fibrosis.

Front Biosci 2002; 7: 496–503.

Dranoff

J.A.

, Masyuk

A.I.

, Kruglov

E.A.

Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia.

Am J Physiol Gastrointest Liver Physiol 2001; 281: G1059–67.

Dranoff

J.A.

Purinergic regulation of bile ductular secretion. In: LaRusso

N.F.

, Alpini

, Le Sage

editors. Pathobiology of biliary epithelia. [In press]

Libbrecht

, Cassiman

, Desmet

, Roskams

The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver.

Liver 2002; 22: 252–8.

Jhandier

M.N.

, Kruglov

E.A.

, Dranoff

J.A.

Portal fibroblasts attenuate proliferation of bile duct epithelia through blockade of purinergic stimulation of MAP kinases. American Association for the Study of Liver Disease, 54th Annual Meeting; 2003 October 24–28; Boston, MA.

10.

Cassiman

, Libbrecht

, Desmet

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

J Hepatol 2002; 36: 200–9.

11.

Knittel

, Kobold

, Piscaglia

Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair.

Histochem Cell Biol 1999; 112: 387–401.

12.

Kinnman

, Francoz

, Barbu

The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis.

Lab Invest 2003; 83: 163–73.

13.

Hashimoto

, Kothary

P.C.

, Raper

S.E.

Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration.

J Surg Res 1999; 81: 164–9.

14.

Knowles

A.F.

, Chiang

W.C.

Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase 2.

Arch Biochem Biophys 2003; 418: 217–27.

15.

Sevigny

, Sundberg

, Braun

Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDasel) and NTP-Dase2 have implications for thromboregulation.

Blood 2002; 99: 2801–9.

16.

Dranoff

J.A.

, Ogawa

, Kruglov

E.A.

Expression of P2Y nucleotide receptors and ecto-nucleotidases in quiescent and activated rat hepatic stellate cells.

Am J Physiol Gastrointest Liver Physiol 2004; 287: G417–24.

17.

Kaczmarek

, Koziak

, Sevigny

Identification and characterization of CD39/vascular ATP diphosphohydrolase.

J Biol Chem 1996; 271: 33116–22.

18.

Enjyoji

, Sevigny

, Lin

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered nemo-stasis and thromboregulation.

Nat Med 1999; 5: 1010–7.

Ectonucleotidase NTPDase2 is Selectively Down-Regulated in Biliary Cirrhosis

Abstract

Background

Aims

Methods

Results

Conclusions

Keywords

Get full access to this article

References